TI "A Slippery Defence Against HIV" AU Thompson, Clare SO Lancet (12/18/93-12/25/93) Vol. 342, No. 8886/8887, P. 1500 AB Mucosal-associated lymphoid tissue accounts for the largest area of immunologically active tissue in the body, the busiest of which is mucosa of the gastrointestinal tract, which is perpetually dealing with pathogens picked up in food. Ways of using this area for host defense have not been extensively explored, but the possibilities for immunotherapy against diseases of the mucosal surface are significant. One of the most exciting new applications is a possible vaccine for HIV. Lehner et al. theorize that stimulation of secretory IgA in the body areas most at risk for HIV transmission, such as the vaginal, rectal, and genitourinary mucosa, will prevent the virus from crossing the epithelium and entering the immunologically active area below. The researchers also hope for a general action on mucosal-associated lymphoid tissue. If their theory is correct, IgA antibodies directed at the gut could produce secretory IgA antibodies in the respiratory, salivary, and genital areas, as well as other mucosal sites. While they sound promising, one must view these theories with caution. The strategy depends heavily on at least one crucial factor: if the vaginal, rectal, or genital epithelium is torn in any way, increased secretory IgA will be fruitless. If the primed T and B cells in the epithelium act as a second line of defense, however, the future of mucosal vaccination is even more promising. Copyright (c) 1993 - Information, Inc., Bethesda, MD. This information is provided by the Centers for Disease Control & Prevention (CDC), National AIDS Clearinghouse as a public service. Non-profit reproduction is encouraged. * Origin: AEGIS/San Juan Capistrano 714.248.2836 (CASAN) (1:103/927) * Provided as a service of THE BACKROOM - NYC * 718-951-8256